menu
    • menu
    [{"orgOrder":0,"company":"MEDIPOST Co., Ltd","sponsor":"Teikoku Seiyaku","pharmaFlowCategory":"D","therapeuticArea":"Musculoskeletal","country":"SOUTH KOREA","productType":"Cell & Gene Therapy","year":"2025","type":"Licensing Agreement","leadProduct":"Mesenchymal Stem Cell Therapy","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Approved FDF","graph3":"MEDIPOST Co., Ltd","amount2":0.02,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Musculoskeletal","amount2New":0.02,"dosageForm":"Implant","sponsorNew":"MEDIPOST Co., Ltd \/ Teikoku Seiyaku","highestDevelopmentStatusID":"15","companyTruncated":"MEDIPOST Co., Ltd \/ Teikoku Seiyaku"}]

    Find Clinical Drug Pipeline Developments & Deals by MEDIPOST Co., Ltd

    Menu

    MEDIPOST Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            MEDIPOST Co., Ltd

                            South Korea arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            MEDIPOST Co., Ltd

                            South Korea arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Mesenchymal Stem Cell Therapy

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Approved FDF

                            Sponsor : Teikoku Seiyaku

                            Deal Size : $18.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Medipost Signs Exclusive License with Teikoku Seiyaku for Cartistem in Japan

                            Details : Through the licensing deal, Mesenchymal Stem Cell Therapy for Knee Osteoarthritis will be advanced, supporting the development of innovative cell & gene therapy solutions.

                            Product Name : Cartistem

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : $8.0 million

                            December 19, 2025

                            Lead Product(s) : Mesenchymal Stem Cell Therapy

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Approved FDF

                            Sponsor : Teikoku Seiyaku

                            Deal Size : $18.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.